pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·Jun 2·1 min read
save

States tighten rules on corporate telehealth, targeting business structures behind direct-to-consumer care

Jun 2, 2026·read at STAT ↗RegulatoryNegative

Telehealth has grown into a multibillion‑dollar industry, with brands like Hims & Hers and Teladoc becoming widely recognized.

Despite their visibility, many patients are unaware that corporate telehealth firms cannot directly practice medicine in most states.

Over 30 states prohibit corporations from providing medical care, so companies partner with independent physician‑owned groups that hold multiple state licenses to serve as a legal firewall.

Lawmakers are increasing scrutiny of these corporate structures, aiming to ensure clinical decisions remain patient‑focused rather than driven by business interests.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “STAT+: Online care is caught in the crossfire as states crack down on corporate medicine”

read at STAT ↗
524 words · retrieved Jun 2
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
ELI LILLY COLILLY
topics
IBD (Crohn's + UC)OncologyVaccines

related stories

  • 4d agoCaribou layoffs could wipe out 90% of staffBioSpace
  • Jun 2910 clinical trials to watch in the second half of 2026BioPharma Dive
  • May 28STAT+: As Ebola outbreak in Central Africa grows, the U.S. turns itself into a fortressSTAT
  • Dec 22Fierce Biotech Fundraising Tracker '26: Soufflé cooks up $135M; Matchpoint makes $150MFierce Biotech
  • 1d agoGSK pledges $800M to add biologics production capabilities in PennsylvaniaBioSpace